Pharmacokinetics of aminolevulinic acid after oral and intravenous administration in dogs

Drug Metabolism and Disposition

Volumn 27, Issue 4, 1999, Pages 432-435

  Dalton, James T ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOG; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG HALF LIFE; DRUG METABOLISM; DYSGEUSIA; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; VOMITING;

ADMINISTRATION, ORAL; AMINOLEVULINIC ACID; ANIMALS; BIOLOGICAL AVAILABILITY; DOGS; HALF-LIFE; HUMANS; INJECTIONS, INTRAVENOUS; MALE; PHOTOSENSITIZING AGENTS; VOMITING;

ANIMALIA; CANIS FAMILIARIS;

EID: 0032943773     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Bedwell J, MacRobert AJ, Phillips D and Bown SG (1992) Fluorescence distribution and photodynamic effect of ALA-induced PPIX in the DMH rat colonic tumour model. Br J Cancer 65:818-824.
2. Benet LZ and Galeazzi RL (1979) Noncompartmental determination of the steady state volume of distribution. J Pharm Sci 68:1071-1074.
3. Benson RC (1988) Treatment of bladder cancer with hematoporphyrin derivatives and laser light. Urology 31 (Suppl):13-17
4. Davies B and Morris T (1993) Physiological parameters in laboratory animals. Pharmacol Res 10:1093-1095.
5. Edwards SR, Shanley BC and Reynoldsson JA (1984) Neuropharmacology of delta-aminolaevulinic acid-I. Effect of acute administration in rodents. Neuropharmacology 23:477-481.
6. Gorchein A and Webber R (1987) Aminolevulinic acid in plasma, cerebrospinal fluid, saliva and erthryrocytes: Studies in normal, uraemic, and porphyric subjects. Clin Sci 72:103-112.
7. Harty JI, Amin M. Wieman TJ. Tseng MT, Ackerman D and Broghamer W (1989) Complications of whole bladder dihematoporphyrin ether photodynamic therapy. J Urol 141:1341-1346.
8. Loh CS, Bedwell J, MacRobert AJ, Krasner N, Phillips D and Bown SG (1992) Photodynamic therapy of the normal rat stomach: A comparative study between di-sulphonated aluminum phthalocyanine and 5-aminolaevulinic acid. Br J Cancer 66:452-462.
9. Loh CS, MacRobcrt AJ, Bedwell J, Regula J, Krasner N and Bown SG (1993b) Oral versus intravenous administration of 5-aminolaevulinic acid for photodynamic therapy. Br J Cancer 68:41-51.
10. Loh CS, Verndon DI, MacRobert AJ, Bedwell J, Bown SG and Brown SB (1993a) Endogenous porphyrin distribution induced by 5-aminolaevulinic acid in the tissue layers of the gastrointestinal tract. J Photochem Photobiol B 20:47-54 .
11. Marcus SL, Sobel RS, Golub AL, Carroll RL, Lundahl S and Shulman DG (1996) Photodynamic therapy (PDT) and photodiagnosis using endogenous photosensitization induced by 5-aminolevulinic acid (ALA): Current clinical and development status. J Clin Laser Med Surg 14:59-66.
12. Marzo A and Rescigno A (1993) Pharmacokinetics of endogenous substances: Some problems and some solutions. Eur J Drug Metab Pharmacokinet 18:77-88.
13. Okayama A, Fujii S and Miura R (1990) Optimized fluorometric determination of urinary delta-aminolevulinic acid by using pre-column derivatization, and identification of the derivative. Clin Chem 36:1494-1497.
14. Peng Q, Evensen JF, Rimington C and Moan JA (1987) A comparison of different photosensitizing dyes with respect to uptake by C3H tumors and tissues of mice. Cancer Lett 36:1-10.